Biopharmaceutical Processing Equipment and Consumables Market Size was valued at USD 44.1 Bn in 2023 and is predicted to reach USD 85.7 Bn by 2031 at a 8.84% CAGR during the forecast period for 2024-2031.
Biopharmaceutical processing equipment and consumables are the goods or gadgets utilized in the production of biopharmaceuticals. The production of drugs from organic or partially artificial sources using various processed tools, such as filtration systems, bioreactors, and division methods, is referred to as biopharmaceutical production. The primary force behind market growth in the biopharmaceutical sector is the growing emphasis on regulatory compliance and quality. Global regulatory agencies have established stringent policies and procedures about the production and handling of biopharmaceuticals. Because of this, there is now a higher need for premium supplies and equipment that satisfy these strict specifications. In response to this need, manufacturers allocate resources toward compliance initiatives, examinations, and surveillance systems. As producers prioritize producing secure and efficient biopharmaceuticals, the industry for consumable biopharmaceutical processing equipment is predicted to expand.
However, the expensive requirements for the security and well-being of the biopharmaceutical processing equipment and consumables industry and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high-low code technology in insurance because of the lack of payment criteria and adequate insurance coverage, the therapeutic procedures have become prohibitively expensive. Biopharmaceutical processing equipment consumption can be expensive, particularly for specialized and cutting-edge goods. Rising expenses may restrict access to novel consumables for less extensive biopharmaceutical businesses or those with fewer expenditures. The COVID-19 epidemic has affected the market, leading to the shutdown of multiple firms to prevent viral transmission among employees. This could impede the industry's growth.
Competitive Landscape
Some of the Major Key Players in the Biopharmaceutical Processing Equipment and Consumables Market are
- 3M Company
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Agilent Technologies, Inc
- Repligen Corporation
- Sartorius AG
- Merck KGaA
- Eppendorf AG
- Solaris Biotechnology Srl
- Other Prominent Players
Market Segmentation:
The biopharmaceutical processing equipment and consumables market is segmented based on product type, application, and end user. Based on product type, the market is segmented into filtration, chromatography, bioreactors, cell culture media, mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, other equipment and consumables, as well as various services. The market is segmented based on application into commercial bioproduction, vaccine manufacturing, mAb production, recombinant protein production, cell and gene therapy production, and research bioproduction. The market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academia and research institutes.
Based on the Product Type, the Filtration Segment is Accounted as a Major Contributor to the Market
Filtration is expected to hold a major global market share in 2023 in the biopharmaceutical processing equipment and consumables market. It is the fundamental requirement for every step of the biotechnology method. In the manufacturing of biopharmaceuticals, filtration is frequently employed to separate constituents. It is utilized in several downstream processes, including clarifying, transitional filtration, crucial finishing filling programs, and initial culture media filtration for sanitizing purposes.
Academia and Research Institutes Segment to Witness Growth at a Rapid Rate
Academia and research institutes use acrylic acid ester mainly because they create novel biological goods and undertake investigations to contribute to the market's growth. Government organizations are essential in overseeing the biopharmaceutical sector and supplying capital for R&D initiatives, especially in countries like the US, Germany, the UK, China, and India.
In the Region, the North American Biopharmaceutical Processing Equipment and Consumables Market Holds a Significant Revenue Share
The North American biopharmaceutical processing equipment and consumables market is expected to register the highest market share in revenue in the near future. It can be attributed to the prevalence of chronic diseases, high and rising healthcare expenditure, an advanced healthcare infrastructure, available reimbursements, and the presence of major market players. In addition, Asia Pacific is projected to grow rapidly in the global biopharmaceutical processing equipment and consumables market due to the huge amount of registered clinical trials linked to the treatments. Additionally, the market is expanding more quickly due to rising awareness of customized medications and the creation of biotechnology startups.
Recent Developments:
- In July 2024, Thermo Fisher Scientific declared that its initial electron microscopic display facility would operate in Taiwan. Situated in the center of the region's electronic production sector, this cutting-edge institution, known as a NanoPort, is built to accommodate the region's expanding demand for sophisticated analysis tools and knowledge. The brand-new building will collaborate with local semiconductor clients and is currently among the six Thermo Fisher NanoPort locations globally.
- In July 2024, Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company") released its Ecological Report, which outlines the organization's significant accomplishments and demonstrates the scope and complexity of its environmental sustainability strategy.
Biopharmaceutical Processing Equipment and Consumables Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 44.1 Bn |
|
Revenue Forecast In 2031 |
USD 85.7 Bn |
|
Growth Rate CAGR |
CAGR of 8.84% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Application, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
3M Company, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., Repligen Corporation, Sartorius AG, Merck KGaA, Eppendorf AG, Solaris Biotechnology Srl, and Other Prominent Players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
